Source link : https://www.newshealth.biz/health-news/obesity-drug-zepbound-approved-for-obstructive-sleep-apnea/
The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The new indication is for use in combination with reduced-calorie diet and increased physical activity. The once-weekly injectable is the first-ever drug treatment for OSA. Until […]
Author : News Health
Publish date : 2024-12-24 11:14:42
Copyright for syndicated content belongs to the linked Source.
Categories